(PharmaNewsWire.Com, March 13, 2018 ) The report on " Cancer Immunotherapy Market by Application - (Breast, Prostate Melanoma, Colorectal, Head & Neck, Lung, and others), by Product Type – (Interferons, Therapeutic cancer vaccines, Monoclonal Antibodies, Adoptive T cell transfer, Checkpoint inhibitors/immune modulators, Oncolytic virus immunotherapy, Cytokines, Adjuvant Immunotherapy, Interleukins, BCG and others) by Mode of Administration – (Intravesical, Intravenous, Oral, Topical), by End users (Hospitals, Clinics) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" is published by Market Data Forecast.
The Global Cancer Immunotherapy Market was priced $ 62 Billion in 2016 and calculable to be growing at a CAGR of 12.40%, to achieve $ 111.23 Billion by 2021, within the mentioned forecast period. Smoking and excessive alcohol intake, are the principal reasons driving the demand for market growth. Other key factors attributing to the growth of the market are an increase in the occurrence of cancer among individuals. Fewer side effects related to cancer immunotherapy and reduced chances of reappearance of cancer are boosting the demand for market growth. However, when compared to other treatments, cancer immunotherapy is costly, and availability of less information is hindering the market growth.
The fragmentation of global Cancer Immunotherapy Market is done on the basis of Mode of Administration, Application, End-users, and product type. On the root of end-users, the Cancer Immunotherapy Market is classified as hospitals and clinics. On the origin of product type, the market is categorized as BCG, Oncolytic virus immunotherapy, Monoclonal Antibodies, Adjuvant Immunotherapy, Adoptive T cell transfer, Checkpoint inhibitors/immune modulators, Cytokines, Therapeutic cancer vaccines, and others.
On the idea of Mode of Administration, the market is segregated into Topical, Intravenous, Intravesical, and Oral. On the basis of application, the Cancer Immunotherapy Market is bifurcated into Head, Breast, Colorectal, Prostate, Lung, Neck, Melanoma, and others.
Based on region, the worldwide Cancer Immunotherapy Market is classified into the Middle East and Africa, Europe, Latin America, and Asia-Pacific, North America. North America accounted for the largest share of the Cancer Immunotherapy Market in 2016. The large share of the North American Cancer Immunotherapy Market can be attributed to increasing awareness about cancer among people by the government. Asia Pacific is second prominent market owing to rise in healthcare expenditure in developing countries.
The various players in the Cancer Immunotherapy Market include Immunomedics, F. Hoffmann-La Roche Ltd, Advaxis, Merck & Co, Novartis Pharmaceuticals Corporation, Celgene Corp, GlaxoSmithKline Pharmaceuticals Limited, Amgen, Bristol-Myers Squibb, Viralytics, AstraZeneca plc, Medivation, and Pfizer.
About MarketDataForecast™- Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
